USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by USANA Health Sciences, Inc. on January 8, 2026. The filing discloses a significant leadership transition within the executive management team of the Utah-based health sciences company.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Executive Departure: Jim Brown has stepped down as Chief Executive Officer (CEO) and President of the Company.
- Advisory Role: Mr. Brown will remain with the Company in an advisory role for a period at the discretion of the Board of Directors.
- Executive Appointment: Kevin Guest, 63, currently serving as Executive Chairman of the Board, has reassumed the role of Chief Executive Officer. He will continue to serve as Chairman of the Board.
Guidance, Outlook, and Compensation
The Compensation Committee has not yet determined the material terms of compensation for either Mr. Brown's separation or Mr. Guest's appointment as CEO. The Committee expects to finalize these terms shortly. In the interim, Mr. Guest will continue to receive his previously approved compensation as Executive Chairman. The Company intends to file an amendment to this Form 8-K to disclose the finalized compensation arrangements once determined.
Investor Verification Checklist
- Verify the finalized compensation terms for Jim Brown's separation and Kevin Guest's CEO appointment in the upcoming Form 8-K amendment.
- Review the press release (Exhibit 99.1) for additional strategic context regarding the leadership transition.
- Monitor future filings for any changes to the Board of Directors or executive committee structure resulting from this transition.